CS logo
small CS logo
Hopital Augustin Morvan; Federation De Cancerologie

Brest, France
Hospital in Brest
2 Av. Foch, 29200 Brest

About Hopital Augustin Morvan; Federation De Cancerologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
9
ERYtech Pharma
2
Gilead Sciences
2
Total Rows: 3

Clinical Trials at Hopital Augustin Morvan; Federation De Cancerologie


During the past decade, Hopital Augustin Morvan; Federation De Cancerologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22001111000000220011221111110011Started TrialsCompleted Trails201520162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer
2010-05-19
2017-12-13
Completed
152
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE)
2012-03-05
2016-07-20
Completed
402
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
2012-09-03
2016-04-30
Terminated
415
A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2014-01-22
2019-01-11
Completed
667
Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma
2014-07-01
2017-11-01
Completed
141
An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast Cancer
2015-01-14
2016-11-10
Completed
510

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Augustin Morvan; Federation De Cancerologie" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 9Hoffmann-La Roche: 9ERYtech Pharma: 2ERYtech Pharma: 2Gilead Sciences: 2Gilead Sciences: 2

Created with Highcharts 11.1.0Top CollaboratorsBreast International Group: 1Breast International Group: 1Genentech, Inc.: 1Genentech, Inc.: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1

Clinical Trials Conditions at Hopital Augustin Morvan; Federation De Cancerologie


According to Clinical.Site data, the most researched conditions in "Hopital Augustin Morvan; Federation De Cancerologie" are "Breast Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Breast Neoplasms" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Hopital Augustin Morvan; Federation De Cancerologie" in a lesser frequency.

Clinical Trials Intervention Types at Hopital Augustin Morvan; Federation De Cancerologie


Most popular intervention types in "Hopital Augustin Morvan; Federation De Cancerologie" are "Drug" (11 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (3 trials), "Gemcitabine" (3 trials), "Paclitaxel" (3 trials), "Trastuzumab" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Hopital Augustin Morvan; Federation De Cancerologie


The vast majority of trials in "Hopital Augustin Morvan; Federation De Cancerologie" are 11 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Hopital Augustin Morvan; Federation De Cancerologie


Currently, there are NaN active trials in "Hopital Augustin Morvan; Federation De Cancerologie". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hopital Augustin Morvan; Federation De Cancerologie, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Augustin Morvan; Federation De Cancerologie, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 6Phase 2: 6Phase 3: 6Phase 3: 6

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Recruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1